Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRAX
PRAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRAX News
Tarsus Accused of Market Manipulation by Culper Research
6d ago
stocktwits
Praxis Drug Review Period Extended by Three Months
Jun 30 2026
NASDAQ.COM
FDA Extends Review Period for Praxis Drug Application
Jun 29 2026
seekingalpha
FDA Extends Review Period for Praxis Drug Application
Jun 29 2026
Newsfilter
Praxis Receives FDA Breakthrough Therapy Designation for Elsunersen
Jun 22 2026
NASDAQ.COM
Praxis Receives FDA Breakthrough Therapy Designation for Seizures
Jun 22 2026
seekingalpha
Praxis Receives Breakthrough Therapy Designation for Elsunersen
Jun 22 2026
Newsfilter
RBC Capital Markets Initiates Praxis Precision with Outperform Rating
Jun 18 2026
seekingalpha
Latest Wall Street Rating Updates
Jun 18 2026
CNBC
Wedbush Lowers Praxis Price Target to $162 After POWER1 Miss
Jun 04 2026
NASDAQ.COM
US Stocks Close at All-Time Highs as AI Investments Surge
Jun 02 2026
NASDAQ.COM
US Stocks Rise Slightly, Tech Stocks Show Strong Rebound
Jun 02 2026
NASDAQ.COM
US Stocks Dip Slightly Amid Tech Sector Pressure
Jun 02 2026
NASDAQ.COM
Praxis Precision Medicines Reports POWER1 Study Failure
Jun 02 2026
seekingalpha
Praxis Precision Medicines Reports POWER1 Study Results for Vormatrigine
Jun 02 2026
NASDAQ.COM
Praxis Pauses Vormatrigine Study Amid Trial Setbacks
Jun 02 2026
stocktwits
Show More News
